Health Tech

Tempus IPO Soars 9% on Nasdaq Debut, Showcasing Investor Confidence in Health Tech

June 15, 2024

Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech Tempus, a company focused on genomic testing and data analysis, made a striking debut on Nasdaq last Friday. …

“Wegovy: The Ultimate Weight-Loss Solution Transforming Lives”

February 12, 2024

Wegovy’s manufacturer, Novo Nordisk, cannot make the drug fast enough Brief: Through the eyes of Danish user Casper Nielsen, the BBC News explores the growing appeal of Novo Nordisk’s weight-loss medication Wegovy. Nielsen talks …